Xue Wu Song

Director of Finance/CFO at BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.

Health Technology

Consumer Services

Profile

Xue Wu Song is currently working as the VP, Chief Financial & Accounting Officer at Beijing Centergate Technologies (Holding) Co., Ltd.
since 2022.
Additionally, Mr. Song is also a Member-Supervisory Board at DUO Pharmaceutical Co., Ltd.
since 2016.
Mr. Song completed their undergraduate degree at Renmin University of China and their graduate degree at Beihang University.

Xue Wu Song active positions

Companies	Position	Start
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.	Director of Finance/CFO	2014-08-25
DUO Pharmaceutical Co., Ltd. DUO Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology DUO Pharmaceutical Co., Ltd. is a holding company that engages in the production of pharmaceutical products. It offers medicines in the form of tablets, capsules, injections, and granules. Its products include tramadol hydrochloride tablets and injections, pediatric paracetamol enema, Vitamin C injections, cephalexin and trimethoprim capsules, glucose injections, and lincomycin hydrochloride injections. The company was founded on December 15, 1999 and is headquartered in Jiamusi, China.	Director/Board Member	2016-01-07

All active positions of Xue Wu Song

Training of Xue Wu Song

Renmin University of China	Undergraduate Degree
Beihang University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Xue Wu Song's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BEIJING CENTERGATE TECHNOLOGIES (HOLDING) CO., LTD.	Health Technology

Private companies	1
DUO Pharmaceutical Co., Ltd. DUO Pharmaceutical Co., Ltd. Pharmaceuticals: GenericHealth Technology DUO Pharmaceutical Co., Ltd. is a holding company that engages in the production of pharmaceutical products. It offers medicines in the form of tablets, capsules, injections, and granules. Its products include tramadol hydrochloride tablets and injections, pediatric paracetamol enema, Vitamin C injections, cephalexin and trimethoprim capsules, glucose injections, and lincomycin hydrochloride injections. The company was founded on December 15, 1999 and is headquartered in Jiamusi, China.	Health Technology